Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment
Clinical trial NCT03329599 · COMPLETED
Trial details
- NCT number
- NCT03329599
- Sponsor
- Northern California Institute of Research and Education
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-14
- Primary completion
- 2021-12-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.